Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics-Reference-Cited by-同舟云学术

Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics

Published:2013-11 Issue:11 Volume:5 Page:1159-1163
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Kaumaya Pravin TP¹

Affiliation:

1. The Ohio State University Wexner Medical Center, Department of Obstetrics & Gynecology, 410 W 10th Avenue N729, Columbus, OH 43210, USA and The Comprehensive Cancer Center, The Ohio State University, 300 W 10th Avenue, Columbus, OH 43210, USA.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.13.128

Reference39 articles.

1. Next-generation peptide vaccines for advanced cancer

2. A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

3. Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice

4. Conformational HER-2/neu B-cell Epitope Peptide Vaccine Designed to Incorporate Two Native Disulfide Bonds Enhances Tumor Cell Binding and Antitumor Activities

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-Associated B Cells in Sarcoma;Cancers;2023-01-19

2. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine;Future Oncology;2020-06-21

3. Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy;Current Cancer Therapy Reviews;2017-11-15

4. Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discovery;SAR and QSAR in Environmental Research;2017-11-02

5. Peptide-Based Cancer Vaccines and Therapeutics for Solid Tumors Overexpressing HER-1, HER-2, HER-3, VEGF and IGF-1R;Comprehensive Medicinal Chemistry III;2017